Ingredients obtained by KnipBio from specialised strains of leaf symbiont bacteria have been demonstrated to offer promising alternatives to fishmeal in aquafeeds, following a number of recent trials. Read more >>
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) today announced that it plans to offer shares of its common stock in…
read moreAugmented and virtual reality devices are the latest trend in consumer tech — but one company’s smart glasses stand…
read moreThere’s a HUGE problem in the health tracking space right now. With so many different devices and apps, there’s…
read moreMyomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced that it…
read moreA former Odessa High School student who is now attending college in Austin is not letting visual impairment get…
read moreNot many people can boast they started their career by launching a company in the 10th grade, but David…
read moreTreatment with Corbus Pharmaceuticals’ investigative therapy lenabasum (formerly known as anabasum) significantly improves the symptoms of diffuse cutaneous systemic…
read moreThe Philadelphia Pediatric Medical Device Consortium, based out of the Children’s Hospital of Philadelphia, has announced seed grants of…
read moreCanned wine is the best thing that’s happened to wine since the invention of the corkscrew. Archer Roose on…
read moreA Williams county man has a whole new outlook on life, thanks to new technology.
It’s called eSight. The electronic…
read more